INTER-PATHOLOGIST READER STUDY
NCT06246903 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2024-02-07
Summary
This is a post study histology analysis from previously obtained pathology slides.
Conditions
- Nevi, Dysplastic
Sponsors & Collaborators
-
Orlucent, Inc
lead INDUSTRY
Principal Investigators
-
Cathy Shachaf, PhD · Founder and President
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-15
- Primary Completion
- 2024-06-20
- Completion
- 2024-08-01
Countries
- United States
Study Locations
More Related Trials
-
Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
NCT00001813 ·Status: COMPLETED
-
Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
NCT00001164 ·Status: COMPLETED
-
Artificial Intelligence Patient App for RDEB SCCs
NCT05843994 ·Status: ACTIVE_NOT_RECRUITING
-
Short Term Observational Study in DEB Patients
NCT02178969 ·Status: COMPLETED
-
Optical Coherence Tomography Imaging in Systemic Sclerosis
NCT04532151 ·Status: COMPLETED ·Phase: NA
-
Identification of Oral Lesions Through an Autofluorescence System
NCT05942794 ·Status: RECRUITING ·Phase: NA
-
Dermoscopy in Diagnosis of Pigmentary Skin Lesions
NCT03542539 ·Status: UNKNOWN
-
Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot
NCT06291142 ·Status: COMPLETED
-
Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.
NCT05168215 ·Status: RECRUITING
-
A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)
NCT06563414 ·Status: RECRUITING
-
Skin Fluorescent Imaging (SFI) System in Patients With Nevi
NCT04368247 ·Status: COMPLETED
-
Diagnostic Role of Renal Biopsy in Patients With Fabry Disease
NCT06801288 ·Status: COMPLETED
-
The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)
NCT02887495 ·Status: COMPLETED
-
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
NCT00936546 ·Status: COMPLETED ·Phase: PHASE2
-
Smartphone Application to Detect Skin Lesions
NCT02740257 ·Status: COMPLETED
-
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
NCT00433485 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Molecular Markers in Cutaneous Inflammation Between Psoriatic Lesional Skin and Healthy Non-lesional Skin
NCT03423004 ·Status: COMPLETED ·Phase: NA
-
Utility of Breath-holding Test in Systemic Sclerosis
NCT04484948 ·Status: COMPLETED ·Phase: NA
-
Bosentan in Digital Ulcers
NCT00319696 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of RANKL Inhibition on UV-induced Immunosuppression
NCT01978483 ·Status: COMPLETED ·Phase: PHASE1
-
Distal Erosions and Nail Psoriasis
NCT02813720 ·Status: UNKNOWN
-
Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids
NCT00709579 ·Status: UNKNOWN ·Phase: PHASE3
-
Nailfold Capillaroscopic Pattern Changes and Its Correlation with Interstitial Lung Disease (ILD) in Systemic Sclerosis (SSc) Patients.
NCT06579651 ·Status: NOT_YET_RECRUITING
-
Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)
NCT02654340 ·Status: TERMINATED
-
Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles
NCT00005781 ·Status: COMPLETED